Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2015 September;67(3) > Minerva Urologica e Nefrologica 2015 September;67(3):201-10

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as

 

REVIEWS  HOT TOPICS IN PROSTATE CANCER 

Minerva Urologica e Nefrologica 2015 September;67(3):201-10

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Magnetic resonance imaging for prostate cancer: what the urologist needs to know

Kiechle J. E. 1, Pahwa S. 2, Gulani V. 2, Kanaan G. 1, Sedelaar J. P. 3, Ponsky L. E. 1

1 Urology Institute, Case Western Reserve University, School of Medicine, University Hospitals Case Medical Center, Cleveland, OH, USA; 2 Department of Radiology, Case Western Reserve University, School of Medicine, University Hospitals Case Medical Center, Cleveland, OH, USA; 3 Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands


PDF


The use of magnetic resonance imaging (MRI) for prostate cancer imaging has been an area of burgeoning research activity with a goal of finding imaging characteristics that will allow for improved diagnosis and surveillance of prostate cancer. This article will review the MRI sequences currently used for imaging the prostate and describe the scoring and reporting system used by radiologists for prostate MRI known as the Prostate Imaging Reporting and Data System (PI-RADS). Current research regarding the role of prostate MRI for patients without prior biopsy, with prior negative biopsy and elevated PSA, and on active surveillance protocols will also be reviewed.

top of page